Organigram Global (NASDAQ:OGI) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Organigram Global (NASDAQ:OGI) from a sell rating to a hold rating in a report released on Saturday morning.

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Organigram Global in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Organigram Global Stock Performance

Shares of NASDAQ:OGI opened at $1.92 on Friday. The firm has a market cap of $259.22 million, a price-to-earnings ratio of 38.41 and a beta of 1.50. The firm has a fifty day moving average price of $1.68 and a 200 day moving average price of $1.58. Organigram Global has a fifty-two week low of $0.85 and a fifty-two week high of $2.08.

Institutional Trading of Organigram Global

A number of large investors have recently made changes to their positions in the business. Baader Bank Aktiengesellschaft purchased a new stake in shares of Organigram Global during the 2nd quarter valued at about $338,000. Clear Harbor Asset Management LLC bought a new stake in shares of Organigram Global in the 2nd quarter valued at approximately $54,000. Vontobel Holding Ltd. increased its position in shares of Organigram Global by 140.5% during the 2nd quarter. Vontobel Holding Ltd. now owns 69,753 shares of the company’s stock valued at $94,000 after purchasing an additional 40,753 shares during the last quarter. Cidel Asset Management Inc. increased its position in shares of Organigram Global by 112.3% during the 2nd quarter. Cidel Asset Management Inc. now owns 37,103 shares of the company’s stock valued at $50,000 after purchasing an additional 19,627 shares during the last quarter. Finally, Tidal Investments LLC raised its holdings in Organigram Global by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 2,646,879 shares of the company’s stock valued at $3,573,000 after buying an additional 124,356 shares during the period. 34.63% of the stock is currently owned by institutional investors.

About Organigram Global

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.